Chapter 3 Market and Technology Background
- Biopharmaceutical Industry Structure
- Origins of Biotechnology
- Involvement of Large Pharmaceutical Companies
- Overview of Biologics
- Biologics Manufacturing
- Biopharmaceutical Manufacturing Process
- The Preparation Process
- Expression Systems for Therapeutic Protein Production
- E. coli Advantages for Microbial Production
- Mammalian Cell Therapeutic Protein Production
- FDA Regulation of Biologics
Chapter 4 Impact of COVID-19 Pandemic
- Introduction
- Short-Term Impact
- Long-Term Impact
- Delayed Approvals for Non-COVID-Related Pharmaceutical Products
- Self-Sufficiency in Pharma Industry
- Progression of COVID-19
- Government Expenditures on COVID-19
- Social Impact of COVID-19
- Impact on Insurance Providers
- Impact on Health Technology Assessment
- Changes in Consumption Trends in Health-Related Products
Chapter 5 Market Dynamics
- Market Drivers
- Overview
- Rising Prevalence of Chronic Diseases
- Advancement in Biologics
- Growing Geriatric Population
- Market Restraints
- Emergence of Biosimilars
- Market Opportunities
- Opportunities in Emerging Nations
Chapter 6 Market Breakdown by Product Segment
- Global Market for Biologic Therapeutic Drugs by Product Segment
- Therapeutic Proteins
- Vaccines
- Others
Chapter 7 Market Breakdown by Region
- Global Market for Biologic Therapeutic Drugs by Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Chapter 8 Competitive Landscape
- Porter's Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of New Entrants
- Threat of Substitutes
- Competitive Rivalry/Degree of Competition
Chapter 9 Company Profiles
- Amgen Inc.
- Baxter
- China Biologic Products Inc.
- Csl Ltd.
- Dendreon Pharmaceuticals Llc
- Eli Lilly And Co.
- F. Hoffmann-La Roche Ltd.
- Glaxosmithkline Plc
- Glycotope Gmbh
- Grifols S.A.
- JSC Pharmstandard
- Kedrion S.P.A.
- Novartis Ag
- Octapharma Ag
- Reliance Life Sciences
- Sanofi
- Teva Pharmaceutical Industries Ltd.
List of Tables
Summary Table: Global Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 1: Biologic Orphan Drugs, by Trade Name and Indication
Table 2: Expenditures on COVID-19 Crisis, by Selected Country
Table 3: Interim Economic Outlook Forecasts, by Country/Region, 2019-2021
Table 4: Number and Distribution of Persons Aged 60 and Over, by Region, 2017 and 2050
Table 5: Global Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 6: Global Market for Biologic Therapeutic Proteins, by Region, Through 2025
Table 7: Global Market for Biologics Therapeutic Vaccines, by Region, Through 2025
Table 8: Global Market for Other Biologic Therapeutic Drug Products, by Region, Through 2025
Table 9: Global Market for Biologic Therapeutic Drugs, by Region, Through 2025
Table 10: North American Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 11: North American Market for Biologic Therapeutic Drugs, by Country, Through 2025
Table 12: European Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 13: European Market for Biologic Therapeutic Drugs, by Country, Through 2025
Table 14: Asia-Pacific Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 15: Asia-Pacific Market for Biologic Therapeutic Drugs, by Country, Through 2025
Table 16: Japanese Market Statistics
Table 17: Latin American Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 18: Middle Eastern and African Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 19: Porter's Five Forces Analysis
Table 20: Amgen Inc.: Product Portfolio
Table 21: Baxter: Product Portfolio
Table 22: Baxter: Recent Developments, 2021
Table 23: China Biologic Products Holdings Inc.: Product Portfolio
Table 24: China Biologic Products Holdings Inc.: Pipeline Plasma Products
Table 25: China Biologic Products Holdings Inc.: Recent Developments, 2017
Table 26: CSL Ltd.: Products Portfolio
Table 27: CSL Ltd.: Recent Developments, 2021
Table 28: Dendreon Pharmaceuticals LLC: Product Portfolio
Table 29: Eli Lilly and Co.: Product Portfolio
Table 30: F. Hoffmann-La Roche Ltd.: Financials, 2019
Table 31: F. Hoffmann-La Roche Ltd.: Revenues, by Business Segment, 2016-2018
Table 32: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 33: GlaxoSmithKline Plc: Financials, 2017-2019
Table 34: GlaxoSmithKline Plc: Products and Services
Table 35: Glycotope GmbH: Product Portfolio
Table 36: Grifols S.A.: Product Portfolio
Table 37: Grifols S.A.: Recent Developments, 2020
Table 38: JSC Pharmstandard: Product Portfolio
Table 39: Kedrion S.p.A.: Products and Services
Table 40: Kedrion S.p.A.: Developments and Strategies
Table 41: Novartis AG: Product Portfolio
Table 42: Octapharma AG: Products and Services
Table 43: Octapharma AG: Recent Developments, 2020
Table 44: Reliance Life Sciences: Product Portfolio
Table 45: Sanofi: Products and Services
Table 46: Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 47: Teva Pharmaceutical Industries Ltd.: Financials, 2017-2019
List of Figures
Summary Figure: Global Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 1: Impact of COVID-19 on the Pharmaceutical Industry
Figure 2: Comparison of GDP Growth, by Country, 2019 and 2020
Figure 3: Global Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 4: Global Market for Biologic Therapeutic Proteins, 2018-2025
Figure 5: Global Market for Biologic Therapeutic Proteins, by Region, 2018-2025
Figure 6: Global Market for Biologics Therapeutic Vaccines, 2018-2025
Figure 7: Global Market for Biologics Therapeutic Vaccines, by Region, 2018-2025
Figure 8: Global Market for Other Biologic Therapeutic Drug Products, 2018-2025
Figure 9: Global Market for Other Biologic Therapeutic Drug Products, by Region, 2018-2025
Figure 10: Global Market for Biologic Therapeutic Drugs, by Region, 2018-2025
Figure 11: Global Market Shares of Biologic Therapeutic Drugs, by Region, 2019
Figure 12: North American Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 13: North American Market Shares of Biologic Therapeutic Drugs, by Country, 2019
Figure 14: U.S. Market for Biologic Therapeutic Drugs, 2018-2025
Figure 15: Canadian Market for Biologic Therapeutic Drugs, 2018-2025
Figure 16: European Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 17: European Market Shares of Biologic Therapeutic Drugs, by Country, 2019
Figure 18: German Market for Biologic Therapeutic Drugs, 2018-2025
Figure 19: U.K. Market for Biologic Therapeutic Drugs, 2018-2025
Figure 20: French Market for Biologic Therapeutic Drugs, 2018-2025
Figure 21: Italian Market for Biologic Therapeutic Drugs, 2018-2025
Figure 22: Spanish Market for Biologic Therapeutic Drugs, 2018-2025
Figure 23: Rest of European Market for Biologic Therapeutic Drugs, 2018-2025
Figure 24: Asia-Pacific Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 25: Asia-Pacific Market Shares of Biologic Therapeutic Drugs, by Country, 2019
Figure 26: Chinese Market for Biologic Therapeutic Drugs, 2018-2025
Figure 27: Japanese Market for Biologic Therapeutic Drugs, 2018-2025
Figure 28: Indian Market for Biologic Therapeutic Drugs, 2018-2025
Figure 29: Rest of Asia-Pacific Market for Biologic Therapeutic Drugs, 2018-2025
Figure 30: Latin American Market for Biologic Therapeutic Drugs, 2018-2025
Figure 31: Latin American Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 32: Middle Eastern and African Market for Biologic Therapeutic Drugs, 2018-2025
Figure 33: Middle Eastern and African Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 34: Amgen Inc.: Annual Revenue, 2015-2019
Figure 35: Amgen Inc.: Revenue Share, by Country, 2019
Figure 36: Baxter: Annual Revenue, 2015-2019
Figure 37: Baxter: Revenue Share, by Business Unit, 2019
Figure 38: Baxter: Revenue Share, by Region, 2019
Figure 39: China Biologic Products Holdings Inc.: Financials, 2015-2019
Figure 40: China Biologic Products Holdings Inc.: Revenue Share, by Segment, 2019
Figure 41: CSL Ltd.: Financials, 2015-2019
Figure 42: CSL Ltd.: Revenue Share, by Segment, 2019
Figure 43: CSL Ltd.: Revenue Share, by Country/Region, 2019
Figure 44: Eli Lilly and Co.: Annual Revenue, 2017-2019
Figure 45: Eli Lilly and Co.: Revenue Share, by Region, 2019
Figure 46: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Segment, 2019
Figure 47: F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, 2019
Figure 48: GlaxoSmithKline Plc: Revenue Share, by Business Segment, 2019
Figure 49: GlaxoSmithKline Plc: Revenue Share, by Region, 2019
Figure 50: Grifols S.A.: Financials, 2015-2019
Figure 51: Grifols S.A.: Revenues Share, by Segment, 2019
Figure 52: Grifols S.A.: Revenue Share, by Region, 2019
Figure 53: Kedrion S.p.A.: Financials, 2015-2019
Figure 54: Kedrion S.p.A.: Revenue Share, by Segment, 2019
Figure 55: Kedrion S.p.A.: Revenue Share, by Region, 2019
Figure 56: Novartis AG.: Annual Revenue, 2015-2019
Figure 57: Novartis AG: Revenue Share, by Region, 2019
Figure 58: Novartis AG: Revenue Share, by Business Segment, 2019
Figure 59: Octapharma AG: Financials, 2015-2019
Figure 60: Octapharma AG: Revenue, by Operating Income, 2015-2019
Figure 61: Sanofi: Annual Revenue, 2017-2019
Figure 62: Sanofi: Revenue Share, by Business Segment, 2019
Figure 63: Sanofi: Revenue Share, by Region, 2019
Figure 64: Teva Pharmaceutical Industries Ltd.: Revenue Share, by Region, 2019"